Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Merck Gets FDA Fast Track for Efinopegdutide, Previews NASH Data Versus Novo’s Semaglutide
BioSpace
Wed, 06/14/23 - 10:08 am
Merck
efinopegdutide
FDA
NASH
fast track
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Fierce Pharma
Tue, 06/13/23 - 10:49 pm
Merck
Keytruda
Bristol Myers Squibb
Ono
patents
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Activist shareholders blast Merck's IRA lawsuit, urge company to reconsider
Fierce Pharma
Fri, 06/9/23 - 11:49 am
Merck
Inflation Reduction Act
legal
shareholders
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
Fri, 06/9/23 - 10:15 am
AstraZeneca
Merck
Lynparza
NICE
UK
ovarian cancer
fallopian tube cancer
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Merck
Inflation Reduction Act
legal
drug pricing
Biogen
Novartis
Genentech
BIO 2023
ASCO: Merck's Keytruda trips in EGFR lung cancer as Roche's Tecentriq fails in kidney cancer
Fierce Pharma
Tue, 06/6/23 - 04:19 pm
ASCO 2023
Merck
Keytruda
EGFR lung cancer
Roche
Tecentriq
kidney cancer
FDA approves Merck's letermovir to prevent CMV in kidney transplant recipients
Healio
Tue, 06/6/23 - 04:16 pm
Merck
FDA
letermovir
CMV
kidney transplants
Prevymis
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Yahoo/Reuters
Tue, 06/6/23 - 10:04 am
ASCO 2023
Merck
Moderna Therapeutics
MRNA
vaccines
skin cancer
Merck sues US government to halt Medicare drug price negotiation
Reuters
Tue, 06/6/23 - 09:59 am
Merck
legal
Inflation Reduction Act
drug pricing
Medicare
ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early lung cancer realm
Fierce Pharma
Sun, 06/4/23 - 04:22 pm
ASCO 2023
Merck
Keytruda
non-small cell lung cancer
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:53 am
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Biopharma Reporter
Wed, 05/31/23 - 11:10 am
vaccines
MRNA
Merck
Asia-Pacific
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Merck and Eisai tease results for renal carcinoma treatment
Clinical Trials Arena
Tue, 05/30/23 - 09:18 pm
Merck
Eisai
ASCO 2023
Lenvima
Keytruda
renal cell carcinoma
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
BioPharma Dive
Thu, 05/25/23 - 08:51 pm
ASCO 2023
antibody-drug conjugate
Merck
BioNTech
Daiichi Sankyo
ASCO: Merck gives final look at Keytruda study in first-line cervical cancer. Will FDA change its mind?
Fierce Pharma
Thu, 05/25/23 - 08:37 pm
ASCO 2023
Merck
Keytruda
cervical cancer
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thu, 05/25/23 - 08:33 pm
ASCO 2023
Merck
Keytruda
Novartis
Kisqali
non-small cell lung cancer
early breast cancer
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
BioSpace
Wed, 05/24/23 - 10:15 am
Merck
vaccines
Gardasil
legal
HPV
side effects
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »